HOUSTON, Nov. 13, 2015 /CNW/ -- OrthoAccel® Technologies, Inc. is ranked #2 in Texas and #69 nationally on Deloitte's 2015 Technology Fast 500, a prestigious ranking that recognizes the fastest growing companies in North America. The only orthodontic company ranked among this year's 500, OrthoAccel manufactures AcceleDent®, an FDA-cleared, Class II medical device that speeds up orthodontic tooth movement by as much as 50 percent. AcceleDent is recommended by many of the industry's leading orthodontists as the fast, safe and gentle solution to accelerate orthodontic treatment.
OrthoAccel, which manufactures AcceleDent in Texas, reported a 1,171 percent growth from 2011 to 2014, making it the fastest growing company in Houston on the Deloitte Technology Fast 500.
"As a relatively young company, OrthoAccel is honored to be among Deloitte's Fast 500 and listed among some of the most respected and dynamic technology brands," said Michael K. Lowe, president and CEO of OrthoAccel. "Our rapid growth is attributed to our talented and motivated team, which maintains laser focus on ensuring professional and consumer audiences understand the benefits of AcceleDent and how it is revolutionizing the orthodontic industry."
A prescription-only device, AcceleDent is available in more than 2,900 orthodontic locations across North America and 360 international locations. Orthodontic patients gently bite on AcceleDent's mouthpiece for 20 minutes daily and light pulsations employed by patented SoftPulse Technology® work at a cellular level to accelerate bone modeling and remodeling in the craniofacial region. Patients report that AcceleDent's light pulsations relieve the pain often associated with orthodontic treatment.
According to the Journal of Clinical Orthodontics, AcceleDent is the most common accelerated treatment technique used by orthodontists. Additionally, 100 percent of patients surveyed report they are satisfied with their experience using AcceleDent and that it was easy to use.
With the American Association of Orthodontists reporting an all-time high of adolescent and adult patients, OrthoAccel board member Brian R. Smith says the market opportunity for OrthoAccel is evident because patients are eager to complete treatment and AcceleDent offers them an easy, non-invasive way to finish faster.
"The Deloitte Fast 500 ranking further recognizes OrthoAccel's position as the leader of the accelerated orthodontic industry and will spur even more momentum for the company," said Smith, who is the managing director of S3 Ventures, a Texas focused venture capital firm. "OrthoAccel's growth within the orthodontic industry is unmatched and the company continues to focus on innovations that enhance the treatment experience for all patients."
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the development, manufacturing and marketing of products to enhance dental care and orthodontic treatment. OrthoAccel developed and markets AcceleDent®, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses via SoftPulse Technology® as a complement to existing orthodontic treatment. More information can be found at acceledent.com.
SOURCE OrthoAccel Technologies, Inc.
For further information: Kristin Taylor, Carbonara Group, 713-524-8170 (office), 850-524-5395 (cell), Kristin@carbonaragroup.com, http://www.acceledent.com